News

Highlights from 2008

March 24, 2008 3rd Millennium has announced the completion of the reengineering of PhosphoSitePlus (www.phosphosite.org), a comprehensive resource provided by Cell Signaling Technology (CST) for information concerning protein modifications and their role in regulating cellular functions. PhosphoSitePlus enables the user to formulate sophisticated queries based on treatments, diseases, cell lines, and tissues, and result in retrieval of bulk data sets. Results of these queries can be downloaded for analysis and model-building. There are provisions for bulk queries that will allow high-throughput labs to determine whether sites from their modification site discovery programs are novel.


Highlights from 2007

October 31, 2007 3rd Millennium announces today that Elaine Freund, Ph.D., formerly the director of Product Management and Application Sciences at Cognia, has joined the Company as Senior Project Scientist. Dr. Freund will lead and coordinate the Integrative Cancer Research workspace (ICR) for the cancer Biomedical Informatics Grid (caBIG™) project sponsored by the National Cancer Institute's Center for Bioinformatics (NCICB). The goal of the project is to speed the delivery of innovative approaches for the prevention and treatment of cancer.


February 12, 2007 3rd Millennium, Inc. announced today that the Center for Comparative and Functional Genomics at the University of Illinois has purchased their award winning Array Repository and Data Analysis System (ARDAS). Located in Urbana-Champaign, the center conducts research on the comparative genetic organization, evolution and function of plant, animal and microbial genomes. Press Release


January 15, 2007 3rd Millennium announces today that Kim Fechtel, Ph.D., formerly the Senior Director of Bioinformatics at Genome Therapeutics Corporation, has joined the Company as Senior Director, Scientific Consulting. Dr. Fechtel will be responsible for business development and act as the Principal Investigator and scientific leader for R&D grants.


Highlights from 2006

October 9, 2006 3rd Millennium announced the release of version 2.5 of its ARDAS™ microarray data management system. Version 2.5 of ARDAS includes general usability and performance enhancements and features for bulk loading of data, integration and exports to external resources and software packages such as GoMiner™, DAVID, GeneSpring®, or PathwayStudio®, and enhanced normalization and linear modeling analytical capabilities.


March 15, 2006 3rd Millennium announced today the release of a new version of its award winning ARDAS™ software. The Array Repository and Data Analysis System provides a complete and fully integrated solution to microarray data acquisition, management, and analysis. ARDAS includes a Laboratory Information Management System (LIMS), a repository and data warehouse, and an Analysis Information Management System (AIMS). Press Release


Highlights from 2005

November 1, 2005 3rd Millennium announced today that it has received a prestigious Small Business Innovation Research Quality Award from the department of defense for its ARDAS™ microarray Bioinformatics platform. The award recognizes exceptional projects for their quality, originality, and innovation of research. Press Release


March 1, 2005 3rd Millennium is selected to lead and coordinate the Vocabularies & Common Data Elements workspace (VCDE) for the cancer Biomedical Informatics Grid (caBIG™) project sponsored by the National Cancer Institute's Center for Bioinformatics (NCICB). The goal of the project is to speed the delivery of innovative approaches for the prevention and treatment of cancer.


January 1, 2005 3rd Millennium receives a Phase II Small Business Innovation Research (SBIR) contract from the Department of Defense to extend its Microarray Repository and Data Analysis System ARDAS™ with sophisticated analytical workflows and integration to external applications and data sources. Press Release


Highlights from 2004

December 20, 2004 3rd Millennium announces that Brian Davis, Ph. D., formerly Director of Database Development at Proteome, has joined the Company as Senior Project Scientist. Press Release


Aug 10, 2004 3rd Millennium receives additional funding from the Department of Defense to extend its Repository and Data Analysis System ARDAS™ to support additional analysis workflows and to integrate to external 3rd party software and tools.


April 15, 2004 3rd Millennium is selected to lead and coordinate the Integrative Cancer Research workspace (ICR) for the cancer Biomedical Informatics Grid (caBIG™) project sponsored by the National Cancer Institute's Center for Bioinformatics (NCICB). The goal of the project is to speed the delivery of innovative approaches for the prevention and treatment of cancer.


January 15, 2004 3rd Millennium receives a Phase I Small Business Innovation Research (SBIR) contract from the Department of Defense to continue the development of its Microarray Repository and Data Analysis system ARDAS™.


Highlights from 2003

December 15, 2003 3rd Millennium releases its Knowledge Management System as open source under the GNU General Public License (GPL) to the Biotech and Pharmaceutical community. Press Release


November 20, 2003 CytRx's subsidiary Araios teams with 3rd Millennium to implement a Scientific Computing Platform for RNAi-Based Diabetes and Obesity Drug Development. Press Release


February 19, 2003 3rd Millennium releases whitepaper titled: Knowledge Management Lagging in Drug Discovery R&D. Press Release


January 27, 2003 3rd Millennium receives Phase II Small Business Innovation Research (SBIR) contract from the Department of Defense to continue development of its Microarray Repository and Data Analysis system ARDAS™. Press Release


Highlights from 2002

October 7, 2002 3rd Millennium announces that Juli Klemm, Ph.D., formerly the Director of Scientific Project Management at Incyte Genomics, has joined the Company as Senior Project Scientist. Press Release


August 6, 2002 The Hereditary Disease Array Group (HDAG) reported important new findings on Huntington's disease from data compiled in the NeuMetrix gene expression database, which was custom-built by 3rd Millennium. Press Release


June 10, 2002 3rd Millennium collaborates with the Hereditary Disease Foundation Array Group (HDAG) to create the largest publicly-available repository of microarray gene expression data to help accelerate Huntington's disease research. Press Release


May 6, 2002 3rd Millennium releases a whitepaper titled: Practical Data Integration in Biopharmaceutical R&D: strategies and technologies. Press Release


February 13, 2002 3rd Millennium receives Phase I Small Business Innovation Research (SBIR) contract from the Department of Defense to develop an innovative Microarray Bioinformatics System. Press Release


Highlights from 2001

December 4, 2001 3rd Millennium implements a Lab Information Management System System (LIMS) for Ardais Corporation. The new system will support the high throughput pathology lab operations that provide high quality data to their Biorepository Management System. Press Release


November 27, 2001 3rd Millennium announces the completion of a custom Bioinformatics System for Biogen to support the integration, workflow, and analysis needs of their core gene expression facility. Press Release


October 9, 2001 3rd Millennium teams with GeneEd and CHI to create a "Microarray Informatics" courseware based on the workshop presented at the CHI Third Annual Pharmacogenomics Conference. Press Release


August 28, 2001 Physiome Sciences Licenses PathwayPrism™ Biological Modeling Technology to 3rd Millennium for the Development of Models for Huntington's disease. Press Release


Highlights from 2000

October 4, 2000 3rd Millennium Awarded $1.8 Million from ATP for Life Sciences Information Management Program for Pharmaceutical Research and Development to develop state of the art software to integrate, analyze, and organize information from gene-based research conducted by biotechnology and pharmaceutical companies worldwide. Press Release


© 2005-2008 3rd Millennium, Inc.